OTCMKTS:SVNDY

Seven and I Q4 2025 Earnings Results & Report

Seven and I logo
$13.92 +0.13 (+0.94%)
As of 03:54 PM Eastern

Seven and I missed analyst earnings expectations but beat on revenue in its Q4 2025 results, released April 9, 2025. The company reported EPS of $0.12 versus the $0.23 consensus estimate, while revenue of $19.70 billion topped the $18.47 billion estimate by $1.23 billion.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Seven and I EPS Results

Actual EPS
$0.12
Consensus EPS
$0.23
Beat/Miss
Missed by -$0.11
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 5 quarters

Seven and I Revenue Results

Actual Revenue
$19.70 billion
Expected Revenue
$18.47 billion
Beat/Miss
Beat by +$1.23 billion
YoY Revenue Growth
N/A

Upcoming Earnings

Seven and I's next earnings date is estimated for Thursday, January 7, 2027, based on past reporting schedules.

Conference Call Resources

Seven and I Q4 2025 Earnings FAQ

Seven and I (OTCMKTS:SVNDY) reported earnings of $0.12 per share for Q4 2025, missing the consensus estimate of $0.23. The report was announced on Wednesday, April 9, 2025.

Seven and I reported revenue of $19.70 billion for Q4 2025, against a consensus estimate of $18.47 billion.

Seven and I's next earnings date is estimated for Thursday, January 7, 2027. MarketBeat tracks confirmed and estimated earnings dates for Seven and I on the company's earnings history page.

Seven and I Earnings Headlines

Analyzing Seven and I (OTCMKTS:SVNDY) and Groupon (NASDAQ:GRPN)
FDA clears next-gen therapy with 10 to 40 times greater potency
Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden. One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.tc pixel
Nomura Remains a Hold on Seven & I Holdings Co (SVNDF)
See More Seven and I Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seven and I? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seven and I and other key companies, straight to your email.

About Seven and I

Seven & i Holdings is a Japan-based retail group whose businesses include convenience stores, supermarkets and other retail operations. Its best-known brand is 7-Eleven, which serves customers through stores in Japan, North America and other international markets. The company’s retail offerings include food, beverages, household goods and everyday services.

The group also operates businesses in Japan under brands including Ito-Yokado, a general merchandise and supermarket retailer. Its activities have included financial services and other customer-focused services alongside retailing.

Seven & i became a holding company in 2005, bringing together businesses with roots in Japanese retail. Its operations span multiple regions, with convenience stores forming a central part of its business.

View Seven and I Profile